Navigation Links
AMRI Announces Fourth Quarter 2012 Adjusted EPS of $0.17
Date:2/12/2013

loss) per diluted share for the 2012 and 2011 reporting periods, please see Table 1 at the end of this press release. AMRI Chairman, President and CEO Thomas E. D'Ambra said, "We are pleased to report fourth quarter and full year results for 2012, which reflect operating improvements largely driven by the record performance in our Large Scale Manufacturing business. In addition, a number of actions taken in prior periods are demonstrating a positive impact on our bottom line. Our overall performance for fiscal year 2012 demonstrates the consistent and positive direction our company is moving as we continue to position and integrate our global facilities and high quality services. Although discovery and early development demand continues to be soft relative to prior periods, we have also delivered progress and entered into new relationships that hold promise for future growth. We are building key long-term relationships with customers that will benefit us in 2013 and beyond. Led by the AMRI SMARTSOURCING™ strategy implemented in the first quarter of 2012, AMRI is well positioned to maintain positive momentum into 2013 and, most importantly, support and help our customers discover, develop and bring to market the exciting drugs of today and tomorrow."

"As we enter 2013 and look beyond as well, we are optimistic about our ability to lead the industry to new business models and relationships, and we are encouraged by the decisions we made throughout 2012 to set us on the right path to continued profitability," added Dr. D'Ambra.

Liquidity and Capital ResourcesAt December 31, 2012, AMRI had cash, cash equivalents, and restricted cash of $28.5 million, compared to $20.2 million at December 31, 2011. These amounts in 2012 include $5.2 million of restricted cash, $5.0 million of which was pledged to collateralize the company's term loan and line of credit.

Total debt at December 31, 2012 was $8.0 million compared to $5.8 million at December 31, 20
'/>"/>

SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Quantum Materials Corporation Announces Non-Heavy Metal (Cadmium-Free) Tetrapod Quantum Dots
2. The In View Series Announces Plans for a New Series on 3D-Printing
3. Elsevier Announces the Launch of a New Journal: Journal of Forensic Radiology and Imaging
4. The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
5. Murray Test Prep Announces the Launch of their Online Tutoring Services
6. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
7. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
8. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
9. DNA Genotek Inc. Announces $10,000 GenoFIND™ Genomic Services Award
10. Spectrum Announces bioWorld Distribution Agreement
11. Life Technologies Announces Fourth Quarter and Fiscal 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Faced with increasing challenges such as costly treatments ... the global healthcare industry today is gradually transforming ... or significantly changing the course of a disease, ... medicine as a viable alternative. Regenerative ... with the potential to resolve unmet medical needs ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... state of the Biophotonics industry.The report provides a basic overview of the industry ... provided for the international markets including development trends, competitive landscape analysis, and key ...
(Date:7/27/2015)... July 27, 2015 Research presented at the ... expand on the studies that led to a fingerprick ... for this disease to receive approval from the World ... breaking Ebola,s grip on West Africa ... enabling healthcare workers to isolate and treat these patients ...
(Date:7/27/2015)... 27, 2015 Junto Health, a company that ... and develop new technology solutions, today announced the launch ... a leader in health care policy consulting. Working together ... a collaborative innovation process while, at the same time, ... public policy, health care finance and the delivery of ...
Breaking Biology Technology:Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4
... or the "Company") (Amex: SNT ) today reported,financial results ... loss for the three month period ended December 31, 2007 ... loss of $1.1 million, or,$0.07 per share, for the three ... was primarily the result of a decrease in revenue and,an ...
... and Medical Affairs, NEW YORK, Feb. 15 ... Lou DeBergalis has joined the,Company as Vice President, Quality ... the Company later this month in the role of,Vice ... will,report directly to Michael S. Weiss, Chief Executive Officer., ...
... SAN DIEGO, Feb. 15 Cadence Pharmaceuticals,Inc. (Nasdaq: ... in-licensing,developing and commercializing proprietary product candidates principally,for use ... has received,commitments from selected investors to purchase up ... purchase price of $5.34 per share pursuant to,an ...
Cached Biology Technology:Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results 2Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results 3Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results 4Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results 5Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results 6Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results 7Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results 8Keryx Biopharmaceuticals Announces Additions to Management Team 2Keryx Biopharmaceuticals Announces Additions to Management Team 3Keryx Biopharmaceuticals Announces Additions to Management Team 4Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering 2
(Date:7/2/2015)... 2015 Research and ... the "Natural Language Processing Market by Type ... Pattern & Image Recognition) - Worldwide Forecast to ... The key vendors occupying the market are 3M, ... Corporation, NetBase Solutions, SAS Institute Inc., Verint Systems ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
(Date:6/25/2015)... LAKE CITY , June 25, 2015  Imagine ... first steps toward a healthier, happier life. That,s exactly ... is designed to do. The cutting-edge, portable health program ... offers real-life solutions to help improve your lifestyle and ... Association awards dinner and gala Wednesday night, USANA,s THA ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... 2010 Tel Aviv University President Professor, ... together a myriad of seemingly unrelated chemical reactions creating a ... Chemistry on April 18 , contributes to our understanding ... motion of molecules or other particles within that medium, determining ...
... increasingly being produced using container nursery systems rather ... field production techniques, successful container production requires a ... sequentially transferred to larger containers, a practice known ... arise when trees are planted either too deep ...
... Combining telephone counseling calls with a daily written diet ... vegetables consumption, according to research published in Preventive ... health care for many reasons, including lack of time, ... Ph.D., research professor in the department of family medicine ...
Cached Biology News:Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry 2Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry 3Planting depth affects popular landscape tree 2Telephone counseling increases daily servings of fruit, vegetables, U-M study says 2
CREB-2 (H-290)...
... Rabbit polyclonal to Parathyroid Hormone Receptor ... tested applications). Antigen: ... extracellular amino acids 99-116 of Human ... Entrez Gene ID: 5746 ...
Anti-CD74 Monoclonal Antibody Description: 200 l Research Focus: cell surface antigens Storage: 4C Shipping Temperature: 4C...
NAP-2 (5C7)...
Biology Products: